A Media Briefing Addressing the Exploding International COVID-19 Crisis: Global Virus Network – Ideas For a Global Vaccination Strategy

June 30, 2021 Drs. Robert Gallo, Christian BrĂ©chot, Sharon Lewin, and Amadou Sall Global Vaccination Vaccination is one of the most effective control measures for human infectious diseases. COVID-19 vaccines, particularly mRNA vaccines, have been very effective, including against the current SARS-CoV-2 variants. Thus, successful vaccination has resulted in mitigating SARS-CoV-2 infection in countries, such…

Read More

Global Virus Network (GVN) Adds Gilead Sciences to GVN Healthcare & Pharma Centers of Excellence Coalition

The Partnership Focuses on Stimulating Collaborations and Training the Next Generation of Virus Researchers to Prepare for and Mitigate Future Global Threats Baltimore, Maryland, USA, June 30, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research…

Read More

GVN Center and Member Spotlight – Yang Liu and Pan Zheng

Members > Spotlights > Yang Liu & Pan Zheng GVN Center and Member Spotlight Yang Liu Global Virus Network Board Member Chief Executive Officer and Chief Scientific Officer, OncoImmune Pan Zheng Global Virus Network Board Member Founder, Senior Vice President and Chief Medical Officer, OncoImmune Research careers of Drs. Yang Liu and Pan Zheng Drs.…

Read More

GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Marion Koopmans

WELCOME TO FEATURING DR. MARION KOOPMANS – JUNE 14, 2021 – “ORIGINS OF SARS-COV-2: THE CHINA MISSION” Marion Koopmans Head of Erasmus University Medical Center Rotterdam Department of Viroscience, Rotterdam, Netherlands GVN Center Director Bio sketch Professor Marion Koopmans, DVM, PhD, focuses on global population level impact of rapidly spreading zoonotic virus infections, with special emphasis…

Read More

Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy

Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy June 21, 2021 One of the consequences of unchecked SARS-CoV-2 infections is the generation of mutations that have the potential to increase infectivity and transmissibility, confer a degree of resistance to vaccines, neutralizing antibodies, and monoclonal antibody therapy, and in some cases generate false…

Read More

GVN Center and Member Spotlight – Aydar Ishmukhametov

GVN Center and Member Spotlight Aydar Ishmukhametov CEO Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences Moscow, Russia GVN Center Director What are you and your institution currently working on regarding COVID-19 At the Chumakov FSC R&D IBP RAS, we developed CoviVac, an inactivated vaccine against SARS-CoV-2,…

Read More

Celdara Medical and Global Virus Network Announce Collaboration to Advance Infectious Disease and Viral Infection Research and Development

The partnership will initially focus on SARS-CoV-2 and future pandemic threats. BALTIMORE, MD and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products to the patients who need them the most, today announced a new strategic collaboration with the…

Read More